dermatitis
Incyte Biosciences UK announces NICE approval for Opzelura for vitiligo
This is the first approved treatment option in the UK for patients with non-segmental vitiligo
Moderna and Merck announce data from melanoma combination therapy study
Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths
AbbVie shares promising phase 3 results for Rinvoq in severe alopecia areata
Around 700,000 people in the US are living with some form of the autoimmune disease
FDA grants fast track designation to Nektar’s rezpegaldesleukin in alopecia areata
Approximately 700,000 people in the US currently have some form of the autoimmune disease
NHS programme to give melanoma patients fast-track access to skin cancer vaccine
The phase 2 study will evaluate Scancell's iSCIB1+ in patients with advanced unresectable melanoma
Regeneron shares positive phase 3 results for Libtayo in high-risk skin cancer
Approximately 1.8 million cases of cutaneous squamous cell carcinoma are diagnosed in the US every year
Merck shares positive ten-year results for Keytruda in advanced melanoma
More than 100,640 cases of the skin cancer are expected to be diagnosed in the US this year
FDA approves Sun Pharma’s oral JAK inhibitor Leqselvi to treat severe alopecia areata
The autoimmune disease currently affects around 700,000 people in the US
Moderna/Merck share positive three-year results for investigational skin cancer vaccine
More than 100,000 new cases of melanoma are expected to be diagnosed in the US in 2024
Almirall survey reveals limited knowledge of most common precancerous skin condition
An estimated 60% of squamous cell carcinoma cases, the second most common skin cancer, develop from AK lesions
Researchers develop microneedle patch to reverse hair loss caused by alopecia areata
The autoimmune skin condition currently affects more than six million people in the US
UK scientists discover two genes offering potential drug targets against skin cancer
The three major types of skin cancer are basal cell carcinoma, squamous cell carcinoma and melanoma